M Veyrac

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 589 citations · Full text

Inflammation, Antimetabolite Therapy, Anti-inflammatory +5

Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Philippe Marteau, Marc Lémann, Philippe Seksik et al. · Gut · 2005 · 409 citations · Full text

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 370 citations

Inflammation, Anti-inflammatory, Infliximab Plus Azathioprine +6

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 234 citations · Full text

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

J. Coelho, Laurent Beaugerie, Jean–Frédéric Colombel et al. · Gut · 2010 · 180 citations